Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Compared to patients without vitamin D deficiency, the proportion of males was significantly higher in those with vitamin D deficiency (63.4% versus. 50.0%, p‐value=.022); other assessed characteristics, including prevalence of underlying diseases, were similar between the two groups (all p‐values >.05).

Source: RESULTS. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Our retrospective cohort study included all patients with confirmed COVID‐19 hospitalized between February 20, 2020, and April 20, 2020, at a designated COVID‐19 hospital, located in the province of Tehran, Iran.

Source: Methods.

In two aforementioned hospitals, the oropharyngeal swab specimens of patients were collected on admission and examined in predetermined laboratories to detect SARS‐CoV‐2 viral nucleic acid using RT‐PCR assay.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The predictive power of serum vitamin D for poor outcomes in COVID‐19 patients

Cohort study · Food Science & Nutrition · 2021

Original publication title

The predictive power of serum vitamin D for poor outcomes in COVID‐19 patients

Hoda Derakhshanian; Hadith Rastad; Sanjoy Ghosh; Marjan Zeinali; Mahsa Ziaee; Tara Khoeini; Mohsen Farrokhpour; Mostafa Qorbani; Mona Ramezani Ghamsari; Hossein Hasani; Zahra Mirzaasgari

© 2021 The Authors. Food Science & Nutrition published by Wiley Periodicals LLC

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Abstract

Considering the high prevalence of vitamin D deficiency worldwide and its relationship with immune response to viral infections, this study attempted to identify the predictive power of serum vitamin D for poor outcomes among the COVID‐19 patients. This retrospective cohort study included all patients with confirmed COVID‐19 hospitalized between February 20, 2020, and April 20, 2020, at a designated COVID‐19 hospital, located in Tehran province, Iran. General characteristics, medical history and clinical symptoms were recorded by trained physicians. Blood parameters including complete blood count, creatinine, lactate dehydrogenase, creatine phosphokinase, erythrocyte sedimentation rate, C‐reactive protein and vitamin D were tested.

This study included 290 hospitalized patients with COVID‐19 (the mean age [SD]: 61.6 [16.9], 56.6% males), of whom 142 had vitamin D concentrations less than 20 ng/ml, defined as vitamin D deficiency. COVID‐19 patients with vitamin D deficiency were more likely to die (Crude OR [95% CI]: 2.30 [1.25 to 4.26]), require ICU (2.06 [1.22 to 3.46]) and invasive mechanical ventilation (2.03 [1.04 to 3.93]) based on univariate logistic regression results. Although, after adjusting for potentials confounders such as gender and age, the association between vitamin D and need to invasive mechanical ventilation lost its significance, adjusted values for the risk of death and ICU requirement were still statistically significant.

Vitamin D deficiency can be considered as a predictor of poor outcomes and mortality in COVID‐19 patients. Therefore, checking serum 25 (OH) D on admission and taking vitamin D supplements according to the prophylactic or treatment protocols is recommended for all COVID‐19 patients.

Authors’ abstract

Abstract

Considering the high prevalence of vitamin D deficiency worldwide and its relationship with immune response to viral infections, this study attempted to identify the predictive power of serum vitamin D for poor outcomes among the COVID‐19 patients. This retrospective cohort study included all patients with confirmed COVID‐19 hospitalized between February 20, 2020, and April 20, 2020, at a designated COVID‐19 hospital, located in Tehran province, Iran. General characteristics, medical history and clinical symptoms were recorded by trained physicians. Blood parameters including complete blood count, creatinine, lactate dehydrogenase, creatine phosphokinase, erythrocyte sedimentation rate, C‐reactive protein and vitamin D were tested.

This study included 290 hospitalized patients with COVID‐19 (the mean age [SD]: 61.6 [16.9], 56.6% males), of whom 142 had vitamin D concentrations less than 20 ng/ml, defined as vitamin D deficiency. COVID‐19 patients with vitamin D deficiency were more likely to die (Crude OR [95% CI]: 2.30 [1.25 to 4.26]), require ICU (2.06 [1.22 to 3.46]) and invasive mechanical ventilation (2.03 [1.04 to 3.93]) based on univariate logistic regression results. Although, after adjusting for potentials confounders such as gender and age, the association between vitamin D and need to invasive mechanical ventilation lost its significance, adjusted values for the risk of death and ICU requirement were still statistically significant.

Vitamin D deficiency can be considered as a predictor of poor outcomes and mortality in COVID‐19 patients. Therefore, checking serum 25 (OH) D on admission and taking vitamin D supplements according to the prophylactic or treatment protocols is recommended for all COVID‐19 patients.

Publication and source details

Original title: The predictive power of serum vitamin D for poor outcomes in COVID‐19 patients

Hoda Derakhshanian; Hadith Rastad; Sanjoy Ghosh; Marjan Zeinali; Mahsa Ziaee; Tara Khoeini; Mohsen Farrokhpour; Mostafa Qorbani; Mona Ramezani Ghamsari; Hossein Hasani; Zahra Mirzaasgari

Food Science & Nutrition · 2021

* Correspondence
Zahra Mirzaasgari, Department of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
Email: mirzaasgari@gmail.com
© 2021 The Authors. Food Science & Nutrition published by Wiley Periodicals LLChttps://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Alborz University of Medical Sciences 10.13039/501100012411Iran University of Science and Technology 10.13039/501100006766

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T11:43:54.610266+00:00

DOI: 10.1002/fsn3.2591 · PMC8565195